Copyright Reports & Markets. All rights reserved.

Global Cancer Supportive Care Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cancer Supportive Care Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cancer Supportive Care Market Size Growth Rate by Product
      • 1.4.2 Nonsteroidal Erythropoietin Stimulating Agents
      • 1.4.3 Opioid Analgesics
      • 1.4.4 Anti-Imflammatory Drugs
      • 1.4.5 Anti-Infective Drugs
      • 1.4.6 Bisphosphonates
      • 1.4.7 Anti-Emetics Drugs
      • 1.4.8 Monoclonal Antibodies
      • 1.4.9 Granulocyte Colony Stimulating Factor
    • 1.5 Market by End User
      • 1.5.1 Global Cancer Supportive Care Market Size Growth Rate by End User
      • 1.5.2 Lung Cancer
      • 1.5.3 Breast Cancer
      • 1.5.4 Prostate Cancer
      • 1.5.5 Liver Cancer
      • 1.5.6 Bladder Cancer
      • 1.5.7 Leukemia
      • 1.5.8 Ovarian Cancer
      • 1.5.9 Melanoma
      • 1.5.10 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cancer Supportive Care Market Size
      • 2.1.1 Global Cancer Supportive Care Revenue 2014-2025
      • 2.1.2 Global Cancer Supportive Care Sales 2014-2025
    • 2.2 Cancer Supportive Care Growth Rate by Regions
      • 2.2.1 Global Cancer Supportive Care Sales by Regions
      • 2.2.2 Global Cancer Supportive Care Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cancer Supportive Care Sales by Manufacturers
      • 3.1.1 Cancer Supportive Care Sales by Manufacturers
      • 3.1.2 Cancer Supportive Care Sales Market Share by Manufacturers
      • 3.1.3 Global Cancer Supportive Care Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Supportive Care Revenue by Manufacturers
      • 3.2.1 Cancer Supportive Care Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cancer Supportive Care Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cancer Supportive Care Price by Manufacturers
    • 3.4 Cancer Supportive Care Manufacturing Base Distribution, Product Types
      • 3.4.1 Cancer Supportive Care Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cancer Supportive Care Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cancer Supportive Care Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cancer Supportive Care Sales by Product
    • 4.2 Global Cancer Supportive Care Revenue by Product
    • 4.3 Cancer Supportive Care Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cancer Supportive Care Breakdown Data by End User

    6 North America

    • 6.1 North America Cancer Supportive Care by Countries
      • 6.1.1 North America Cancer Supportive Care Sales by Countries
      • 6.1.2 North America Cancer Supportive Care Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cancer Supportive Care by Product
    • 6.3 North America Cancer Supportive Care by End User

    7 Europe

    • 7.1 Europe Cancer Supportive Care by Countries
      • 7.1.1 Europe Cancer Supportive Care Sales by Countries
      • 7.1.2 Europe Cancer Supportive Care Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cancer Supportive Care by Product
    • 7.3 Europe Cancer Supportive Care by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cancer Supportive Care by Countries
      • 8.1.1 Asia Pacific Cancer Supportive Care Sales by Countries
      • 8.1.2 Asia Pacific Cancer Supportive Care Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cancer Supportive Care by Product
    • 8.3 Asia Pacific Cancer Supportive Care by End User

    9 Central & South America

    • 9.1 Central & South America Cancer Supportive Care by Countries
      • 9.1.1 Central & South America Cancer Supportive Care Sales by Countries
      • 9.1.2 Central & South America Cancer Supportive Care Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cancer Supportive Care by Product
    • 9.3 Central & South America Cancer Supportive Care by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cancer Supportive Care by Countries
      • 10.1.1 Middle East and Africa Cancer Supportive Care Sales by Countries
      • 10.1.2 Middle East and Africa Cancer Supportive Care Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cancer Supportive Care by Product
    • 10.3 Middle East and Africa Cancer Supportive Care by End User

    11 Company Profiles

    • 11.1 Amgen
      • 11.1.1 Amgen Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Amgen Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Amgen Cancer Supportive Care Products Offered
      • 11.1.5 Amgen Recent Development
    • 11.2 Helsinn Healthcare
      • 11.2.1 Helsinn Healthcare Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Helsinn Healthcare Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Helsinn Healthcare Cancer Supportive Care Products Offered
      • 11.2.5 Helsinn Healthcare Recent Development
    • 11.3 Johnson &Johnson
      • 11.3.1 Johnson &Johnson Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Johnson &Johnson Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Johnson &Johnson Cancer Supportive Care Products Offered
      • 11.3.5 Johnson &Johnson Recent Development
    • 11.4 Merck
      • 11.4.1 Merck Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck Cancer Supportive Care Products Offered
      • 11.4.5 Merck Recent Development
    • 11.5 F. Hoffmann-La Roche
      • 11.5.1 F. Hoffmann-La Roche Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 F. Hoffmann-La Roche Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 F. Hoffmann-La Roche Cancer Supportive Care Products Offered
      • 11.5.5 F. Hoffmann-La Roche Recent Development
    • 11.6 GlaxoSmithKline
      • 11.6.1 GlaxoSmithKline Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 GlaxoSmithKline Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 GlaxoSmithKline Cancer Supportive Care Products Offered
      • 11.6.5 GlaxoSmithKline Recent Development
    • 11.7 Novartis
      • 11.7.1 Novartis Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Novartis Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Novartis Cancer Supportive Care Products Offered
      • 11.7.5 Novartis Recent Development
    • 11.8 TESARO
      • 11.8.1 TESARO Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 TESARO Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 TESARO Cancer Supportive Care Products Offered
      • 11.8.5 TESARO Recent Development
    • 11.9 Teva Pharmaceutical Industries
      • 11.9.1 Teva Pharmaceutical Industries Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Teva Pharmaceutical Industries Cancer Supportive Care Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Teva Pharmaceutical Industries Cancer Supportive Care Products Offered
      • 11.9.5 Teva Pharmaceutical Industries Recent Development

    12 Future Forecast

    • 12.1 Cancer Supportive Care Market Forecast by Regions
      • 12.1.1 Global Cancer Supportive Care Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cancer Supportive Care Revenue Forecast by Regions 2019-2025
    • 12.2 Cancer Supportive Care Market Forecast by Product
      • 12.2.1 Global Cancer Supportive Care Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cancer Supportive Care Revenue Forecast by Product 2019-2025
    • 12.3 Cancer Supportive Care Market Forecast by End User
    • 12.4 North America Cancer Supportive Care Forecast
    • 12.5 Europe Cancer Supportive Care Forecast
    • 12.6 Asia Pacific Cancer Supportive Care Forecast
    • 12.7 Central & South America Cancer Supportive Care Forecast
    • 12.8 Middle East and Africa Cancer Supportive Care Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cancer Supportive Care Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
      With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
      The high investment in the oncology segment and pharmaceutical industry in US and Canada, and the presence of several large vendors operating in US contribute to the growth of the palliative cancer care market in the Americas. Additionally, constant R&D activities in the oncology sector, strong economic condition, and huge investments in the healthcare segment further contribute to the market growth.
      The global Cancer Supportive Care market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Supportive Care market based on company, product type, end user and key regions.

      This report studies the global market size of Cancer Supportive Care in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Supportive Care in these regions.
      This research report categorizes the global Cancer Supportive Care market by top players/brands, region, type and end user. This report also studies the global Cancer Supportive Care market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Amgen
      Helsinn Healthcare
      Johnson &Johnson
      Merck
      F. Hoffmann-La Roche
      GlaxoSmithKline
      Novartis
      TESARO
      Teva Pharmaceutical Industries

      Market size by Product
      Nonsteroidal Erythropoietin Stimulating Agents
      Opioid Analgesics
      Anti-Imflammatory Drugs
      Anti-Infective Drugs
      Bisphosphonates
      Anti-Emetics Drugs
      Monoclonal Antibodies
      Granulocyte Colony Stimulating Factor
      Market size by End User
      Lung Cancer
      Breast Cancer
      Prostate Cancer
      Liver Cancer
      Bladder Cancer
      Leukemia
      Ovarian Cancer
      Melanoma
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cancer Supportive Care market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cancer Supportive Care market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cancer Supportive Care companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cancer Supportive Care submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cancer Supportive Care are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Supportive Care market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now